• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Frequency of spontaneous p53 mutations (CpG site) in breast cancer in Japan.

作者信息

Sasa M, Kondo K, Komaki K, Uyama T, Morimoto T, Monden Y

机构信息

Second Department of Surgery, School of Medicine, University of Tokushima, Japan.

出版信息

Breast Cancer Res Treat. 1993 Sep;27(3):247-52. doi: 10.1007/BF00665694.

DOI:10.1007/BF00665694
PMID:8312582
Abstract

Sixty-five tumors of invasive ductal carcinoma of the breast were examined for p53 alteration by the reverse transcription-polymerase chain reaction-single strand conformation polymorphism (RT-PCR-SSCP) method and sequencing analysis. In total, 16 samples (24.6%) showed p53 gene alteration. Sixteen of these alterations were evaluated by sequencing analysis, and 15 showed missense point mutations while one showed a 9-base pair deletion. In the 15 point mutations, G:C to A:T transitions constituted the majority (53%), and five tumors (33%) had a transition at the CpG site, which are mutational patterns not commonly found in breast tumors from Europe and America. On the other hand, there were no G:C to T:A transversions in our cases, which were frequently observed transversions in Europe and America. These p53 mutation patterns in breast cancer in Japan are not similar to those in Europe and America reported by Hollstein et al. and Coles et al.. These findings suggest that there are some differences between mechanisms of breast cancer in Japan and in Europe and America.

摘要

相似文献

1
Frequency of spontaneous p53 mutations (CpG site) in breast cancer in Japan.
Breast Cancer Res Treat. 1993 Sep;27(3):247-52. doi: 10.1007/BF00665694.
2
p53 mutations and overexpressions in Japanese breast cancer.日本乳腺癌中的p53突变与过表达
Eur J Surg Oncol. 1995 Dec;21(6):595-600. doi: 10.1016/s0748-7983(95)95047-8.
3
p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries.日本人类前列腺癌中的p53基因突变:日本与西方国家之间不同的突变谱
Jpn J Cancer Res. 1994 Sep;85(9):904-10. doi: 10.1111/j.1349-7006.1994.tb02967.x.
4
Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.原发性和转移性胰腺导管病变的分子病理学:散发性和家族性病变中p53、mdm-2和p21/WAF-1基因的突变及表达分析
Cancer. 1997 Feb 15;79(4):700-16.
5
Frequency and pattern of p53 gene mutation in a cohort of Spanish women with node-negative breast cancer.
Int J Oncol. 1999 Sep;15(3):555-8. doi: 10.3892/ijo.15.3.555.
6
High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.台湾乳腺癌中p53基因改变时G/C颠换的高频率。
Cancer Lett. 2004 Apr 15;207(1):59-67. doi: 10.1016/j.canlet.2003.12.005.
7
The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.乳腺癌中从非典型导管增生进展为浸润性病变过程中p53突变的时间及特征
J Mol Med (Berl). 2001 Nov;79(11):648-55. doi: 10.1007/s001090100269.
8
p53 alteration correlates with negative ER, negative PgR, and high histologic grade in breast cancer.p53改变与乳腺癌中雌激素受体阴性、孕激素受体阴性及高组织学分级相关。
J Surg Oncol. 1994 May;56(1):46-50. doi: 10.1002/jso.2930560110.
9
Detection of p53 gene mutations in aspiration biopsy specimens from suspected breast cancers by polymerase chain reaction-single strand conformation polymorphism analysis.通过聚合酶链反应-单链构象多态性分析检测疑似乳腺癌细针穿刺活检标本中的p53基因突变。
Jpn J Cancer Res. 1995 Feb;86(2):140-5. doi: 10.1111/j.1349-7006.1995.tb03031.x.
10
Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.意大利佛罗伦萨周边高发地区胃腺癌中K-ras和p53基因的突变
Cancer Res. 1995 Jun 15;55(12):2665-72.

引用本文的文献

1
High frequency of p53 protein expression in thymic carcinoma but not in thymoma.p53蛋白在胸腺癌中表达频率高,但在胸腺瘤中不高。
Br J Cancer. 1997;76(10):1361-6. doi: 10.1038/bjc.1997.561.
2
High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population.日本女性(乳腺癌低发人群)原发性乳腺癌中p53基因突变的高频率。
Br J Cancer. 1996 Apr;73(8):896-901. doi: 10.1038/bjc.1996.179.
3
Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancer.

本文引用的文献

1
p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.高组织学分级的导管内和浸润性乳腺癌中的p53突变与c-erbB-2扩增
Jpn J Cancer Res. 1993 Apr;84(4):394-401. doi: 10.1111/j.1349-7006.1993.tb00149.x.
2
The effect of westernization on urine estrogens, frequency of ovulation, and breast cancer risk. A study of ethnic Chinese women in the Orient and the USA.西方化对尿雌激素、排卵频率及乳腺癌风险的影响。一项针对东方和美国华裔女性的研究。
Cancer. 1984 Jan 1;53(1):187-92. doi: 10.1002/1097-0142(19840101)53:1<187::aid-cncr2820530133>3.0.co;2-n.
3
Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenous aprt gene in CHO cells.
在人乳腺癌存档石蜡包埋组织中,p53蛋白的核内积聚与p53基因的突变相关。
Jpn J Cancer Res. 1994 Aug;85(8):825-30. doi: 10.1111/j.1349-7006.1994.tb02954.x.
Somat Cell Mol Genet. 1988 Jul;14(4):393-400. doi: 10.1007/BF01534647.
4
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.采用酸性硫氰酸胍-苯酚-氯仿萃取法一步分离RNA的方法。
Anal Biochem. 1987 Apr;162(1):156-9. doi: 10.1006/abio.1987.9999.
5
The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model.在突变模型下脊椎动物基因组中CpG二核苷酸的预期平衡。
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4692-6. doi: 10.1073/pnas.87.12.4692.
6
Suppression of human colorectal carcinoma cell growth by wild-type p53.野生型p53对人结肠癌细胞生长的抑制作用。
Science. 1990 Aug 24;249(4971):912-5. doi: 10.1126/science.2144057.
7
Genetic basis for p53 overexpression in human breast cancer.人类乳腺癌中p53过表达的遗传基础。
Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):5006-10. doi: 10.1073/pnas.88.11.5006.
8
Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.人类乳腺癌中17号染色体p13区域序列缺失及p53基因突变
Oncogene. 1991 Mar;6(3):413-21.
9
Mutations in p53 as potential molecular markers for human breast cancer.p53基因的突变作为人类乳腺癌潜在的分子标志物。
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10657-61. doi: 10.1073/pnas.88.23.10657.
10
p53 mutations in human cancers.人类癌症中的p53基因突变。
Science. 1991 Jul 5;253(5015):49-53. doi: 10.1126/science.1905840.